<DOC>
	<DOCNO>NCT00278434</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention use certain drug keep tumor form , grow , come back . Zoledronate may prevent growth cervical cancer block blood flow cervical intraepithelial neoplasia cell . The use zoledronate may keep cancer forming . PURPOSE : This randomize study well zoledronate work treat patient cervical intraepithelial neoplasia 2/3 3 .</brief_summary>
	<brief_title>Zoledronate Treating Patients With Cervical Intraepithelial Neoplasia 2/3 3</brief_title>
	<detailed_description>OBJECTIVES : - Assess clinical response , term lesion size histological grade , zoledronate patient cervical intraepithelial neoplasia 2/3 3 . OUTLINE : This randomize , placebo-controlled , double-blind , pilot study . Patients stratify accord degree cervical intraepithelial neoplasia ( CIN ) ( CIN2/3 v CIN3 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive zoledronate IV 20 minute day 1 . - Arm II : Patients receive placebo IV 20 minute day 1 . In arm , treatment repeat every 21 day 3 course . In week 8 , patient undergo surgical resection comprise loop excision cone biopsy . After completion study treatment , patient follow week 10 telephone . PROJECTED ACCRUAL : A total 44 patient accrue study .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsy confirm cervical intraepithelial neoplasia ( CIN ) 2/3 3 Planning loop excision cone biopsy Diagnosis within 2 month prior study entry Standard histological grade accord Richart Visible lesion colposcopy No unsatisfactory colposcopy lesion extend endocervical canal visualize entirely colposcopy No suspicion invasive cervical cancer cytology , histology colposcopy No cytologic evidence glandular atypia dysplasia PATIENT CHARACTERISTICS : Creatinine normal Screening laboratory value within normal range ( e.g. , complete blood count , liver function test , renal panel , electrolyte ) Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Able read speak English Spanish No known hypersensitivity bisphosphonates Not immunocompromised No known HIV positivity No aspirinsensitive asthma due association bisphosphonates bronchoconstriction No unexplained abnormal vaginal bleeding PRIOR CONCURRENT THERAPY : No concurrent loop diuretic , aminoglycosides , nephrotoxic drug , immunosuppressive drug , investigational agent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>cervical intraepithelial neoplasia grade 2</keyword>
	<keyword>cervical intraepithelial neoplasia grade 3</keyword>
</DOC>